Max Maletta

Max Maletta has a strong background in business development, sales, and scientific research. Max'smost recent position is as a Senior Commercial Business Development Manager at GenScript ProBio, starting in 2023. Prior to this, they worked at Thermo Fisher Scientific for six years, where they were involved in sales business development and overall business development in the EMEA region. During their time at Thermo Fisher Scientific, Max consistently exceeded annual booking quotas and implemented innovative strategies that generated significant revenue. Max also developed a go-to-market strategy for the EMEA region, including market segmentation, customer mapping, positioning, value proposition, and promotion.

Before their time at Thermo Fisher Scientific, Max worked as a Krios (Cryo-TEM) Supervisor at NeCEN and as a Cryo-EM specialist at NKI-AVL. At Eyen, they served as the CSO and successfully marketed their software product to the pharmaceutical industry. Max also developed technical product demonstrations for their Cryo-EM offerings and promoted their digital platform at conferences in the EMEA region.

Max's earlier experience includes a research fellowship at NKI-AVL and a post-doc position at IGBMC. At IGBMC, they led research projects and published high impact factor publications related to protein/DNA interactions. Max also had a brief post-doc role at NOTOX, focusing on work package 3.

Overall, Max Maletta's work experience showcases their ability to drive business growth, develop successful strategies, and contribute to scientific research in various roles within the life sciences industry.

Max Maletta earned a Bachelor's degree in Chemistry from Università degli Studi di Napoli Federico II, completing their studies from 1998 to 2003. Following that, they pursued a Doctor of Philosophy (PhD) in Chemistry at Università degli Studi di Firenze between 2004 and 2007.